DRI Healthcare receives put price of about US$178 million for EKTERLY royalty interest
Reuters2026/08/11 12:17- DRI Healthcare received about USD 178 million from exercising its put option tied to its EKTERLY royalty participation right.
- The put was exercised on July 10, 2026, following Chiesi Group’s acquisition of KalVista Pharmaceuticals.
- Receipt of the put price completed the transaction, terminating the EKTERLY royalty participation right.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cantex Mine Development closes second tranche of private placement for $1.01 million proceeds
PVH CEO Stefan Larsson acquires USD 999,999 of common shares
The rebound of the yen may only be temporary, Morgan Stanley bets on arbitrage trades making a comeback, USD/JPY expected to rise to 163.
Morgan Stanley believes that the recent strengthening of the Japanese yen is mainly due to the unwinding of short-term arbitrage trades and market bets on Japanese capital repatriation, rather than any substantial improvement in fundamentals.

Edwards Lifesciences CVP, TAVR Daniel J. Lippis disposes of 619 common shares worth $54,168.69